The mode of action of the p-chlorophenylalanine in these animals is not clear. pChlorophenylalanine, in vitro, is not an appreciable inhibitor of phenylalanine hydroxylase, and this is apparently so in vivo also as the lowering of phenylalanine hydroxylase activity shows a delayed response to p-chlorophenylalanine treatment. However, the decrease in phenylalanine hydroxylase activity is not caused by the accumulation ofp-chlorophenylalanine or an inhibitory metabolite of this compound because, when livers fromp-chlorophenylalanine-treated rats are stored at -20°C until the enzyme activity has decayed, no inhibition of freshly prepared purified phenylalanine hydroxylase is observed. One possible explanation is that inhibition is due to a metabolite of p-chlorophenyla!anine which is a tightly bound non-competitive inhibitor, excess of which is further metabolized. It is also possible that the decreased activity results from some incorporation of p-chlorophenylalanine into the enzyme protein, so producing an impaired protein, a suggestion already made by Gil et al. (1970).
decade, very little is known about its metabolism and excretion in man or in other animal species. It is known that those structural modifications of the cortisol molecule which are needed to increase the biological potency also decrease the rate of metabolism (Florini & Buyske, 1959; Fotherby & James, 1972) . This decrease in metabolism is reflected by an increased excretion of the unchanged drug, a slower removal from plasma, and hence a prolonged plasma half-life of the compound. In the dog, plasma half-life of dexamethasone is 60min compared with 34 and 44min for corticosterone and cortisol respectively (Florini et al., 1961) . Haque et al. (1972) reported a half-life of 252min for dexamethasone in man. They also found that dexamethasone was converted into unidentified polar metabolites which were excreted unconjugated in the urine. We have investigated the metabolism of dexamethasone in the rat and the preliminary findings are reported here.
[l ,2-3H]Dexamethasone (43.5pCilpmol) was given intraperitoneally at a dose of 0.23prnollkg to male 48-day-old Wistar albino rats. Urine and faeces were collected at 6 and 24h and thereafter every 24h for 4 days. Urinary radioactivity was fractionated into free and conjugated steroids according to Frantz et al. (1961) and Edwards et (Recknagel & Litteria, 1956 ). The amount of unchanged dexamethasone in the urine was determined by a reverse-isotope dilution method. The flow-sheet diagram of the entire separation procedure employed is given in Scheme 1.
The results in Table 1 show the excretion of radioactivity after the intraperitoneal administration of a single dose of [3Hldexamethasone in the rat. The percentage of the dosed radioactivity excreted in the urine in 4 days was 30.4%, 18 % being excreted in the first 6 h. The faecal excretion in 24 and 48 h was 11.7 and 36.9 % of the dose respectively and the total excretion in 96h rose to 43.6%. In total 74% of the dose was accounted for in the urine and faeces in 4 days. Most of the radioactivity in the 0-6h urine sample (18% of dose) was found in the unconjugated steroid fraction (15.3 % of dose, 85 % of total urinary radioactivity). Further examination of the unconjugated steroids indicated the presence of two major components in this fraction, unchanged dexamethasone (3.5% of dose; 20% of total urinary radioactivity) and a metabolite more polar than dexamethasone (5.8% of dose; 38% of total urinary radioactivity). A lesser amount of radioactivity was associated with the conjugate fraction (2.7 of dose; 15 % of total urinary radioactivity), which on hydrolysis with p-glucuronidase yielded predominantly dexamethasone. 18.0k 1.0 0.3k0.1
These findings with dexamethasone and a previous report (Tredger et al., 1973) on betamethasone (the 16p-methyl isomer) show that in the rat the urinary excretion rates of these two compounds are the same. In contrast, the faecal excretion of dexamethasone is considerably slower than that of betamethasone. In 48 h after drug administration 36.9% of the dosed radioactivity was excreted in the faeces compared with 54.4% observed with betamethasone (Tredger et a/., 1973) . The presence of a high proportion of free steroids in the metabolites of urine agrees with previous reports on synthetic corticosteroids (Butler & Gray, 1970; Haque et al., 1972) . In the human, the urinary free steroids after dexamethasone administration consisted of unchanged drug and three polar metabolites (Haque et al., 1972) . The relative amounts of these metabolites are not known. From our investigations it appears that 32% of the urinary radioactivity in the rat is associated with one polar metabolite of dexamethasone. Chromatographic studies of this metabolite and dexamethasone compared with that of 6-hydroxybetamethasone and betamethasone indicate that this dexamethasone metabolite is likely to be 6-hydroxydexamethasone.
